Fentanyl vs Moxetumomab Pasudotox

## Fentanyl vs Moxetumomab Pasudotox: Overview

This comparison examines the pharmacological differences between **Fentanyl** and **Moxetumomab Pasudotox**.

## Mechanism of Action

**Fentanyl**: Highly potent synthetic mu-opioid receptor agonist approximately 100 times more potent than morphine.

## Pharmacokinetics

**Half-life**: Fentanyl — 2-4 hours; Moxetumomab Pasudotox — N/A.

## Chemical Properties

**Molecular Formula**: Fentanyl — C22H28N2O; Moxetumomab Pasudotox — N/A.

**Molecular Weight**: Fentanyl — 336.4700 g/mol; Moxetumomab Pasudotox — N/A.

**Type**: Fentanyl — Small molecule; Moxetumomab Pasudotox — Antibody drug conjugate.